Sponsor Dossier
Johnson & Johnson
Sponsor Dossier for Johnson & Johnson. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AGAROL
- Brand: Allergy
- Brand: BANLICE
- Brand: BENADRYL
- Brand: BUDAMAX AQUEOUS NASAL SPRAY
- Brand: Codral
- Brand: COMBANTRIN
- Brand: COMBANTRIN-1
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): Adhesive bandage
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): Exudate-absorbent dressing, hydrophilic-gel
- Device (sponsor): Adhesive tape, <specify>
- Device (sponsor): Dressing, compression
- Device (sponsor): Corn dressing
- Device (sponsor): Wound hydrogel dressing, sterile
- Device (sponsor): Adhesive bandage
- Device (sponsor): Bandage, adhesive
- Device (sponsor): Bandage, adhesive
About
Johnson & Johnson Pacific Pty Ltd is an Australian Private Company with ABN 73001121446, registered in NSW. The company is active and operates under several trading names including Aveeno, BAND-AID, Codral, and Listerine.
Portfolio
Johnson & Johnson has 29 brands on the ARTG, of which 5 are indexable. Three brands have Product Information on file, two brands have at least one PBS-listed item, and two brands have PBAC outcomes on record. No brands have AusPARs on record.
Therapeutic focus
— Dermatology: 7 brands — Respiratory: 6 brands — Infectious Disease: 4 brands — Gastroenterology: 4 brands — Ophthalmology: 2 brands — Pain & Anaesthesia: 2 brands — Complementary Medicine: 1 brand — Other: 1 brand — Endocrinology: 1 brand — Immunology: 1 brand
PBS footprint
Two brands in Johnson & Johnson's portfolio have at least one PBS-listed item, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
Johnson & Johnson's latest PBAC outcome was recorded on 2024-11-01, with two brands holding PBAC outcomes on record.